David Redfern appointed as new Chairman of ViiV Healthcare
Editor | March 3, 2011
Issued: Friday 25 February 2011, London UK
GlaxoSmithKline (GSK), ViiV Healthcare, and Pfizer today announced the appointment of David Redfern as the new Chairman of the Board for ViiV Healthcare with effect from 1st April 2011, following the retirement of Julian Heslop. David will continue to serve as Chief Strategy Officer at GSK, which owns a [...]










